FDA Accepts sNDA for Delgocitinib Cream to Treat Pediatric Chronic Hand Eczema – Dermatology Times

eczemarelief
2 months ago
Share



FDA Accepts sNDA for Delgocitinib Cream to Treat Pediatric Chronic Hand Eczema  Dermatology Times



Source link

Tags: Accepts, Chronic, Cream, Delgocitinib, Dermatology, eczema, FDA, Hand, pediatric, sNDA, Times, treat
Leave a Comment
Previous Article
Delgocitinib Sustains Quality of Life Gains Through 52 Weeks in Chronic Hand Eczema – Dermatology Times
Next Article
This biopharma stock could more than double on oral eczema treatment, Goldman Sachs says – CNBC
Post Comment